This site is intended for Healthcare Professionals only
Back to CKS

Palliative care

Palliative care - general issues

Last revised in July 2026

Palliative care is defined as the active holistic care of people with advanced, progressive illness.

Palliative care - general issues: Summary

  • Palliative care is defined as the active holistic care of people with advanced, progressive illness.
  • Professionals providing general palliative care services should:
    • Be involved as early as possible after diagnosis.
    • Aim to meet the needs of the person and family members and/or carers within the limits of their knowledge and competence.
    • Seek specialist advice or refer the person to specialist services, if needed.
  • During the course of the illness, the needs of the person, family members and/or carers should be assessed and managed at key points, such as at the time of diagnosis, around treatment episodes, as treatments end, at the time of any relapse, and when death is approaching. This may include:
    • Offering to discuss an estimate of the person's prognosis, to help advance care planning.
    • Assessing and managing symptoms such as pain, nausea and vomiting, constipation, breathlessness, agitation, and confusion, including any reversible causes.
    • Assessing and managing any psychological, social, cultural, religious, or spiritual needs.
    • Reviewing medications, de-prescribing unnecessary medications, and arranging anticipatory prescribing of medications.
    • Asking about personal goals of treatment including ceilings for care, wishes for cardiopulmonary resuscitation, and preferred care setting and place of death.
    • Offering sources of information and support.
    • Arranging regular review.
  • Supportive care in the terminal phase of illness and last days of life should include:
    • Assessing the person's communication needs, understanding of their illness, and mental capacity.
    • Involving the person, family members and/or carers in decision-making about care, depending on the person's wishes and clinical judgement.
    • Discussing likely prognosis, what to expect in the terminal phase of illness, and any fears or concerns.
    • Reviewing the advance care plan including any advance statement, and the wishes and goals of the person.
    • Supporting the person to drink and maintain hydration if they wish and are able to, and considering a time-limited trial of clinically-assisted hydration depending on the likely relative benefits and risks, and the person's symptoms and wishes.
    • Offering non-drug and drug strategies for symptom management, to maintain the person's comfort and dignity without causing unacceptable adverse effects.
    • Arranging anticipatory prescribing of medications such as morphine, midazolam, cyclizine, and hyoscine butylbromide for new or developing symptoms so they can be treated without delay.
    • Liaising with other members of the multidisciplinary general or specialist palliative care team about the person's care needs and prognosis.
    • Seeking specialist palliative care advice about supportive care and symptom control if needed.
    • Ensuring that family members/carers are aware how and who to contact if symptoms are uncontrolled and when the person dies.

Have I got the right topic?

From age 16 years onwards.

There are separate CKS topics on Delirium, Palliative care - constipation, Palliative care - cough, Palliative care - dyspnoea, Palliative care - malignant skin ulcer, Palliative care - nausea and vomiting, Palliative care - oral, Palliative cancer care - pain, and Palliative care - secretions. ​​​​​​​ ​​​​​​​ ​​​​​​​ ​​​​​​​ 

The target audience for this CKS topic is healthcare professionals working within the NHS in the UK, and providing first contact or primary healthcare.

How up-to-date is this topic?

Changes

July 2026 — reviewed. A literature search was conducted in June 2026 to identify evidence-based guidelines, UK policy, systematic reviews, and key randomized controlled trials published since the last revision of this topic. The Scenario on Communication has been deleted and the content incorporated into the Scenarios on 'Assessment and management approach' and 'The terminal phase'. Various web links to patient and carer information have been added to the topic.

Previous changes

April 2025 — minor update. QOF indicators removed in line with NHS England's 2025 Quality and Outcomes Framework.

December 2023 — minor update. Recommendations relating to COVID-19 infection have been removed from this topic.

June 2023 — minor update.  Replaced a link to the updated Prognostic Indicator Guidance.

July 2022 — minor update. Added new NICE guideline reference in the advice relating to COVID-19.

March 2022 — minor update. Reference to Marie Curie in this topic has been updated to reflect a change in the charity's name. 

March 2021 — reviewed. A literature search was conducted in February 2021 to identify evidence-based guidelines, UK policy, systematic reviews, and key randomized controlled trials published since the last revision of this topic. No major changes to recommendations have been made.

August 2020 — minor update. New NICE quality standard QS194 added.

April 2020 — minor update. New management scenario created to provide information regarding COVID-19.  Additional information added about the provisions for anticipatory prescribing during the pandemic conditions. 

July 2015 to October 2016 — reviewed. Literature searches were conducted in September 2016 to identify evidence-based guidelines, UK policy, systematic reviews, and key randomized controlled trials published since the last revision of this topic. There have been structural changes to the topic and changes to the recommendations have been updated in line with NICE guidance Care of dying adults in the last days of life [NICE, 2015].

July 2015 — topic title changed to reflect broader topic coverage than specifically cancer care.

July 2014 — minor update. The text has been updated to replace the Liverpool Care Pathway with new standards of care that have been issued by the Leadership Alliance for the Care of Dying People.

June 2013 — minor update. The 2013 QOF options for local implementation have been added to this topic.

September 2012 — reviewed. A literature search was conducted in August 2012 to identify evidence-based guidelines, UK policy, systematic reviews, and key RCTs published since the last revision of this topic. No major changes to recommendations have been made.

April 2012 — minor update. The 2012/2013 QOF indicators have been added to this topic. 

June 2011 — minor update. Information on the End of Life Care Patient Charter from the Royal College of General Practitioners and Royal College of Nursing added to the section on. 

June 2011 — minor update. The 2011/2012 QOF indicators have been added to this topic. 

February 2011 — topic structure revised to ensure consistency across CKS topics — no changes to clinical recommendations have been made.

July 2010 — updated. The recommendations from the General Medical Council's guidance for doctors, Treatment and care towards the end of life: good practice in decision making have been included. Issued in August 2010.

April 2009 — minor update. The agreed changes to the Quality and Outcomes Framework (QOF) for palliative care have been updated. 

August 2007 — minor typographical update to the Clinical Summaries (Management approach, Communication, and Prognostic issues). 

March to June 2007 — this is a new CKS topic developed following a structured literature review. The evidence-base has been reviewed in detail, and recommendations are more clearly justified and transparently linked to the supporting evidence.

Update

New evidence

Evidence-based guidelines

No new evidence-based guidelines since 1 June 2026.

HTAs (Health Technology Assessments)

No new HTAs since 1 June 2026.

Economic appraisals

No new economic appraisals relevant to England since 1 June 2026.

Systematic reviews and meta-analyses

No new systematic reviews or meta-analysis which reach the CKS threshold for inclusion since 1 June 2026.

Primary evidence

No new primary evidence which reaches the CKS threshold for inclusion published since 1 June 2026.

New policies

No new policies since  1 June 2026.

New safety alerts

No new safety alerts since 1 June 2026.

Changes in product availability

No changes in product availability since 1 June 2026.

Goals and outcome measures

Goals

To support primary healthcare professionals to:

  • Assess that a person has entered the terminal phase of their illness.
  • Assess the person's physical, psychosocial, and spiritual needs promptly and at regular intervals, depending on the clinical context and the person's wishes.
  • Discuss and manage the person's symptoms, hopes, and fears and offer information about prognosis and advance care planning, depending on the person's wishes.
  • Assess the need for anticipatory prescribing of medication.
  • Enable the person to be cared for and die in their preferred care setting wherever possible.
  • Involve the person, family members, and/or carers in discussions about management where appropriate.

Outcome measures

No outcome measures were found during the review of this topic.

Audit criteria

No audit criteria were found during the review of this topic.

QOF indicators

No QOF indicators were found during the review of this topic.

QIPP - Options for local implementation

No QIPP indicators were found during the review of this topic.

NICE quality standards

End of life care for adults

  • Adults who are likely to be approaching the end of their life are identified using a systematic approach.
  • Adults approaching the end of their life have opportunities to discuss advance care planning.
  • Adults approaching the end of their life receive care that is coordinated between health and social care practitioners within and across different services and organisations.
  • Adults approaching the end of their life and their carers have access to support 24 hours a day, 7 days a week.
  • Carers providing end of life care to people at home are supported to access local services that can provide assistance.

[NICE, 2021a]

Decision-making and mental capacity

  • People aged 16 and over who may lack capacity to make decisions are supported with decision-making in a way that reflects their individual circumstances and meets their particular needs.
  • People aged 16 and over at risk of losing capacity to make decisions, and those with fluctuating capacity, are given the opportunity to discuss advance care planning at each health and social care review.
  • People aged 16 and over who are assessed as lacking capacity to make a particular decision at the time that decision needs to be made, have a clear record of the reasons why they lack capacity and the practicable steps taken to support them.
  • People aged 16 and over who lack capacity to make a particular decision at the time that decision needs to be made have their wishes, feelings, values and beliefs accounted for in best interests decisions.

[NICE, 2020]

Background information

What is palliative care?

  • The World Health Organization (WHO) defines palliative care as follows [WHO, 2002]:
    • 'Palliative care is an approach that improves the quality of life of patients and their families facing the problems associated with life-threatening illness, through the prevention and relief of suffering by means of early identification and impeccable assessment and treatment of pain and other problems, physical, psychosocial, and spiritual.'
    • Palliative care:
      • Provides relief from pain and other distressing symptoms.
      • Affirms life and regards dying as a normal process.
      • Intends neither to hasten nor postpone death.
      • Integrates the psychological and spiritual aspects of patient care.
      • Offers a support system to help patients live as actively as possible until death.
      • Offers a support system to help the family cope during the person's illness and in their own bereavement.
      • Uses a team approach to address the needs of people at the end of their lives, and their families, including bereavement counselling, if indicated.
      • Will enhance quality of life, and may also positively influence the course of illness.
      • Is applicable early in the course of illness, in conjunction with other therapies that are intended to prolong life, such as chemotherapy or radiation therapy, and includes those investigations needed to better understand and manage distressing clinical complications.'
  • Expert opinion in a palliative care textbook notes that palliative care [Regnard, 2010]:
    • Recognises that it cannot remove all distress generated by loss, but that people can be helped to shift their focus of hope and cope with those losses.
    • Provides a path through the physical, psychological, spiritual, and social distress that helps the person, partner, family, and professional achieve a worthwhile quality of life.
    • Provides a therapeutic environment in which the distress can be safely and effectively expressed with sufficient skills and experience.
    • Creates a therapeutic partnership with the person, partner, family, and professionals through direct help, support, advice, research, education, and policy or strategy development.

General palliative care

  • Primary care healthcare professionals such as the person's GP and/or district nursing service should be involved as early as possible after a palliative diagnosis.
  • Much of the support given to people is from professionals who are not specialists in palliative care. Professionals providing general palliative care services (such as members of the primary care team) should aim to meet the needs of a person and family members/carers within the limits of their knowledge and competence. Seek specialist advice or refer the person to the local multidisciplinary specialist palliative care service for support or advice if needed, depending on clinical judgement.
  • The aim of general palliative care is to provide:
    • Information for the person and their family/carers, with signposting to relevant services.
    • Accurate and holistic assessment of a person's needs.
    • Co-ordination of care teams in and out of hours and across boundaries of care.
    • Basic levels of symptom control.
    • Psychological, social, spiritual, and practical support.
    • Open and sensitive communication with the person, their family/carers, and professional colleagues.
      • Effective communication enables professionals to exchange information, plan interventions, and share responsibility for the person's care.
      • Documentation, especially using multidisciplinary records and clinic letters, facilitates communication between professionals.
    • Continuity of care where possible, for example by nominating a 'key worker' who can oversee the person's care.

[Regnard, 2010]

Specialist palliative care

Specialist palliative care services manage complex palliative care problems that cannot be dealt with by general services. Ideally, professionals who are not specialists in palliative care, who care for people with advanced cancer, should have access to specialist advice at all times.

  • Specialist palliative care services may be provided by statutory and voluntary organizations. Care may be provided in community, hospital, and hospice settings (the latter for people with complex problems that cannot be managed adequately in other settings).
  • The palliative care team may include any or all of the following specialities:
    • Palliative medicine consultants and doctors.
    • Palliative care nurses including nurse specialists and/or Macmillan nurses or Marie Curie nurses. The person and/or family members can self-refer to the nursing teams, or referral can be made from primary care, depending on local availability and referral pathways.
      • Macmillan nurses provide support and information to people with cancer and their families. They do not usually provide 'hands-on' care, but give advice to the primary care team, for example about medication for symptom control such as pain, nausea, vomiting, agitation, and/or breathlessness. The person and/or family members can self-refer to the Macmillan nursing team or referral can be made from primary care, depending on local availability.
      • Marie Curie provides nurses who care for terminally ill people and give them the choice of dying at home supported by their families. Marie Curie nurses can provide hands-on care at home through the day or night.
    • Palliative care pharmacists.
    • Physiotherapists.
    • Occupational therapists.
    • Counsellors (including for bereavement support) and/or psychologists.
    • Dietitians.
    • Speech and language therapists. 
    • Social workers.
    • Spiritual advisers.
    • Benefits advisers.
    • Complementary therapists.

[Regnard, 2010; Cherny, 2015]

Management

Scenario: Assessment and management approach

From age 16 years onwards.

How should I assess and manage the person's physical symptoms?

  • Assess the person's physical needs at key points during the course of the illness (such as at the time of diagnosis, around treatment episodes, as treatments end, at the time of any relapse, and when death is approaching). This should include:
    • Assessing symptoms such as pain, nausea and vomiting, constipation, breathlessness, agitation, and confusion, including any reversible causes.
    • Setting treatment goals.
    • Reviewing the person regularly.
    • Arranging referral to or seek advice from specialist palliative care services if needed.
  • Be proactive and ask about symptoms, rather than waiting for the person to report them.
    • Ask about the impact of each symptom on the person's life including time of onset, frequency, duration, severity, exacerbating and relieving factors, and how it affects daily functioning.
    • Be aware that different mechanisms may be responsible for physical symptoms (for example vomiting may be due to hypercalcaemia or gastric outflow obstruction if the person has underlying cancer).
    • Be aware that all symptoms may be worsened by sleep disturbance, exhaustion, anxiety, and/or depression.
  • Ensure that any prescribed drug treatment is still necessary and helpful, and aim to deprescribe any medication that is no longer providing symptomatic benefit, such as statins, or that may cause harm. The British Geriatric Society clinical guide Pragmatic prescribing to reduce harm for older people with moderate to severe frailty may be helpful.
    • Do not delay starting treatment as symptoms can become more difficult to manage the longer they are left untreated.
    • If symptoms are persisting, prescribe regular treatment rather than treatment on an 'as required' basis. See the section on Supportive care in the terminal phase for more information.
    • Discuss and agree on achievable treatment goals with the person and family members/carers if appropriate.

Basis for recommendation

These recommendations are largely based on guidance from the National Institute for Health and Care Excellence (NICE) guideline Care of dying adults in the last days of life [NICE, 2021b], the General Medical Council (GMC) guidance Treatment and care towards the end of life: good practice in decision making [GMC, 2024], the British Geriatrics Society (BGS) clinical guide Pragmatic prescribing to reduce harm for older people with moderate to severe frailty [BGS, 2025], and expert opinion in palliative care textbooks [Regnard, 2010; Cherny, 2015]  [Twycross, 2021]. They are also pragmatic, based on what CKS considers to be good clinical practice.

  • The recommendation to be proactive asking about symptoms is based on expert opinion in a palliative textbook [Regnard, 2010]. It is also pragmatic, based on what CKS considers to be good clinical practice.
  • The recommendation to review necessary drug treatment is extrapolated from the NICE guideline [NICE, 2021b] and is also based on the BGS clinical guide [BGS, 2025].
  • The recommendation not to delay starting treatment is based on expert opinion in a palliative textbook [Regnard, 2010].
  • The recommendations to prescribe regular treatment for persistent symptoms and to agree on achievable treatment goals are based on the NICE guideline [NICE, 2021b].

How should I assess and manage the person's psychological needs?

  • Assess the person's psychological state at key points during the course of the illness (such as at the time of diagnosis, around treatment episodes, as treatments end, at the time of any relapse, and when death is approaching).
  • If the person or family members/carers have significant levels of psychological distress, offer prompt referral to the specialist palliative care service for counselling and/or additional psychological support. The appropriate psychological intervention will depend on the person's current and previous history, the level of support available, and their prognosis.
    • Psychological assessments and interventions should be undertaken in a quiet, comfortable, and private setting.
    • Staff providing psychological care should be adequately trained, supervised, and supported.
    • If there is a severe mental health problem, seek urgent or emergency psychiatric intervention, depending on clinical judgement.
    • The Marie Curie (website www.mariecurie.org.uk) information Coping with a terminal diagnosis may be helpful.

Basis for recommendation

These recommendations are largely based on the National Institute for Health and Care Excellence (NICE) guideline Care of dying adults in the last days of life [NICE, 2021b] and expert opinion in palliative care textbooks [Regnard, 2010; Cherny, 2015; Twycross, 2021].

  • The recommendation when to assess the person's psychological state is pragmatic, based on what CKS considers to be good clinical practice.
    • Advanced illness may result in anger due to unrealised ambitions, loss of control, feelings of hopelessness, depression, persistent symptoms, and spiritual conflicts, as well as an accompanying features of pain and anticipatory grief. Similarly, anxiety is common in advanced disease, but may be missed in more than 50% of people, and may be associated with loss of appetite, depression, breathlessness, and provision of inadequate information [Regnard, 2010].
    • Expert opinion in another palliative care textbook notes that relatives of people who are seriously ill have higher levels of anxiety, depression, and psychological distress than the general population [Cherny, 2015].
  • The recommendations about referral for additional psychological support are extrapolated from expert opinion in a palliative care textbook [Regnard, 2010]. They are also pragmatic, based on what CKS considers to be good clinical practice.

How should I assess the person's social needs?

  • Assess the person's social needs at key points during the course of the illness (such as at the time of diagnosis, around treatment episodes, as treatments end, at the time of any relapse, and when death is approaching).
    • Be aware that assessment of need can be difficult because some people and family members/carers may be reluctant to ask for help or be unaware of help available.
  • Social care and support needs may include:
    • Emotional support.
    • Help with personal care including care at night (such as bathing and dressing), housework, shopping, provision of meals.
    • Practical aids (for example equipment, mobility aids, or wheelchairs).
    • Caring for dependents (such as children or elderly relatives).
    • Advice about family and personal relationships.
    • Advice about work, income, and employment issues and/or any benefits they or their carers are entitled to. The Marie Curie (website www.mariecurie.org.uk) information on Work and terminal illness may be helpful
  • Be aware that social support may be provided by local authorities, NHS, or voluntary organizations, such as respite or day care, support groups, volunteer visitors, assisted transport, and bereavement care.

Basis for recommendation

These recommendations are largely based on the National Institute for Health and Care Excellence (NICE) guideline Care of dying adults in the last days of life [NICE, 2021b] and expert opinion in a textbook on palliative care [Cherny, 2015]. They are also pragmatic, based on what CKS considers to be good clinical practice.

  • The recommendation when to assess the person's social needs is pragmatic, based on what CKS considers to be good clinical practice.
  • The information about possible social care and support needs is based on the NICE guideline [NICE, 2021b]. It is also pragmatic, based on what CKS considers to be good clinical practice.
  • The information about the possible provision of social care is extrapolated from the NICE guideline [NICE, 2021b]. It is also pragmatic, based on what CKS considers to be good clinical practice.

How should I assess the person's religious or spiritual needs?

  • Assess the person's spiritual needs at key points during the course of the illness (such as at the time of diagnosis, around treatment episodes, as treatments end, at the time of any relapse, and when death is approaching).
    • Spiritual need relates to a person's search for meaning within their life. Religion is a means of expressing underlying spirituality, but spiritual belief may not always be expressed in a religious way.
  • Ensure that the person and family members/carers have access to staff who are sensitive to their spiritual needs.
    • Spiritual support may range from an informal sharing of ideas about life, death, and the ultimate purpose of our existence, to the provision of formalized religious ritual.
  • Spiritual support and care for people who are receiving palliative treatment or at the end of life may include:
    • Listening to the person's experience and discussing their questions.
    • Affirming the person's humanity.
    • Protecting the person's self-worth, dignity, and identity.
    • Ensuring that spiritual care is offered as part of a holistic approach to health that also includes psychological, social, and emotional care.
  • Be aware that spiritual support and care may be provided by the multidisciplinary specialist palliative care team, appointed spiritual caregivers, and local community resources for spiritual care.

Basis for recommendation

These recommendations are largely based on the National Institute for Health and Care Excellence (NICE) guideline Care of dying adults in the last days of life  [NICE, 2021b] and expert opinion in textbooks of palliative medicine [Cherny, 2015; Twycross, 2021].

  • The recommendation when to assess the person's spiritual needs is pragmatic, based on what CKS considers to be good clinical practice.
  • Expert opinion in a palliative care textbook notes that 'naming and acknowledging spiritual distress allows for a greater awareness of what the patient is experiencing and thus increases possibilities for resolution'. Spiritual care may allow a person to find meaning and have the opportunity for love, compassion, and partnership as they reach the final stages of their illness [Cherny, 2015].
  • Expert opinion in an additional palliative care textbook notes that 'the basis of spiritual care is acceptance and affirmation'. This includes treating people with respect and dignity, showing that they are regarded as 'fellow humans of worth'. It states that spiritual and emotional wellbeing often overlap, and spirituality can result in positive emotions such as awe, contentment, gratitude, peace, and acceptance. When helping to manage spiritual concerns, it notes that palliative care teams generally have access to multifaith chaplaincy services which can help people to discuss and explore any concerns in a safe, non-judgemental environment [Twycross, 2021].

How should I address the needs of the family and carers?

  • Offer family members and carers the opportunity for their support and information needs to be assessed separately from the person receiving palliative care. They may have specific concerns such as:
    • Fear of the person dying.
    • Anxiety about an emergency occurring (such as what constitutes an emergency and how to deal with it).
    • Feelings of inadequacy regarding caring for the person at home (such as lack of knowledge about how to make the person comfortable or appropriate handling and lifting techniques).
    • The need to suppress their emotions to protect the person they are caring for.
    • Financial concerns.
    • Altered role and lifestyle.
  • Offer family members and carers the opportunity to be involved during clinical reviews and decision-making about treatment and care, depending on the wishes of the person receiving palliative care.
  • Ensure that family members and carers are made aware of local sources of information, advice, and support, to address their own needs, especially at demanding times in the person's illness, and/or when extra help may be needed.
  • Offer additional family/carer support to help with symptom control and address any concerns, if appropriate:
    • Facilitate communication between the person, their family members/carers, and healthcare professionals.
    • Recognize and address areas of stress in other aspects of a person's life, such as work or looking after dependents including children or elderly relatives.
    • Educate about additional skills and knowledge that may be needed to help keep the person comfortable.
    • Discuss aspects of care such as pain management, to reduce anxiety about potential drug addiction or tolerance. See the CKS topic on Palliative cancer care - pain for more information.
    • Encourage the family member/carer to talk about their fears, concerns, uncertainty, and any emotional strain.
    • Provide information about the person's death and what to expect when death is approaching. The Marie Curie website (www.mariecurie.org.uk) has information on End of life stages timeline, What happens in the last weeks of life, and Final moments of life.

Basis for recommendation

These recommendations are based on the National Institute for Health and Care Excellence (NICE) guideline Care of dying adults in the last days of life [NICE, 2021b], the General Medical Council (GMC) publication Treatment and care towards the end of life: good practice in decision-making [GMC, 2024], and expert opinion in a textbook of palliative medicine [Cherny, 2015]. They are also pragmatic, based on what CKS considers to be good clinical practice.

  • The recommendation to assess the assess the needs of family members and carers separately is extrapolated from expert opinion in a palliative care textbook [Cherny, 2015].
    • It notes that 'at the same time that family members are adjusting to the impact of serious illness and its uncertainty, many are also expected to take on the complex role of primary caregiver'. Tasks for family members may include collecting and giving medications; helping manage symptoms including nausea, vomiting, pain, and emotional distress; washing and other personal care; meal preparation and ensuring the person is nourished; laundry; seeing visitors and answering telephone calls friends and relatives. These can all be physically and emotionally overwhelming, and cause additional distress to the family/carer. In addition, regular roles such as being a partner, parent, or child may be lost, when intimacy is needed at an already stressful time [Cherny, 2015].
    • Family members and carers may also need support in dealing with feelings such as inadequacy, guilt, anxiety, fear, and grief. They may also benefit from help managing the personal impact of caring, such as sleep disturbance, weight loss, maintaining family dynamics, and coping with altered roles and life choices [Cherny, 2015].
    • There may be multiple direct and indirect costs associated with performing a caring role, such that at least 25% of family carers are unable to continue employment with associated income losses, and many carers lose friends and opportunities for participation in sport or other social interests [Cherny, 2015].
  • The recommendation to involve family members and carers in decision-making is extrapolated from the NICE guideline [NICE, 2021b], the GMC publication [GMC, 2024], and expert opinion in a palliative care textbook [Cherny, 2015].
  • The recommendation to provide sources of information and support is based on expert opinion in a palliative care textbook [Cherny, 2015]. It is also pragmatic, based on what CKS considers to be good clinical practice.
  • The recommendations to provide additional support are based on the NICE guideline [NICE, 2021b] and expert opinion in a palliative care textbook [Cherny, 2015]. They are also pragmatic, based on what CKS considers to be good clinical practice.

Scenario: Terminal phase

From age 16 years onwards.

How should I assess the person's prognosis and offer advance care planning?

  • Discuss with the person their disease status, progression, and estimated prognosis, if they wish.
    • Estimating the person's prognosis may help in planning appropriate treatment and care. If prognosis is not discussed or predictions are inaccurate, the person may make inappropriate treatment decisions, or inadequately prepare for death.
    • The Gold Standards Framework (GSF, website www.goldstandardsframework.org.uk) publication  Proactive Identification Guidance (PIG) can be used by healthcare professionals to estimate prognosis, including the question 'Would you be surprised if this person were to die in the next 6 to 12 months?' to try to identify people nearing the end of their lives.
    • Some people may request not to know their prognosis. This should be respected and they should be given the opportunity to discuss it again at a later date, if they wish.
  • Discussing a person's prognosis should involve:
    • Identifying the person's own thoughts regarding their prognosis, particularly if there has been a noticeable deterioration in their condition.
    • Explaining the difficulty of providing an accurate prognosis.
    • Providing an estimate only (for example days, weeks, months, or years), not a guarantee of what will happen. Be aware that risks associated with assessing disease prognosis include:
      • Overestimating the length of survival — families may feel 'robbed' of time with their relative.
      • Underestimating the length of survival — the person and their family may question the credibility of the source of information.
  • Offer an opportunity to discuss and document advance care planning with the person.
    • Ask if they would like a family member/carer to be present when making decisions about their care.
    • Discuss their preferences, hopes, and wishes for care, including preferred care setting and preferred place of death.
    • Discuss realistic personal goals, including treatment options and ceilings of care for symptom management. See the section on Supportive care in the terminal phase for more information.
    • Discuss their wishes for hydration, nutrition, and cardiopulmonary resuscitation (CPR).
    • Ask about any needs for care after death, including any expressed views about organ or tissue donation.
    • Review and update the advance care plan as the person's situation or views change.
    • Advise on useful patient and carer information including the GSF Thinking ahead booklet and ACP in 5 simple steps information, and the Marie Curie (website www.mariecurie.org.uk) information Planning your care in advance.
    • The General Medical Council (GMC) publication Treatment and care towards the end of life: good practice in decision making (2024) provides information for healthcare professionals about decision-making, capacity, advance care planning including advance requests for treatment and advance refusals of treatment, nutrition and hydration, CPR, and care after death.

Basis for recommendation

These recommendations are largely based on the National Institute for Health and Care Excellence (NICE) guideline Care of dying adults in the last days of life [NICE, 2021b], the Gold Standards Framework (GSF) and Royal College of General Practitioners (RGCP) publication Proactive Identification Guidance (PIG)  [Gold Standards Framework, 2022], the General Medical Council (GMC) publication Treatment and care towards the end of life: good practice in decision making [GMC, 2024], and expert opinion in textbooks on palliative care  [Regnard, 2010; Cherny, 2015; Twycross, 2021].

  • The recommendation to discuss the person's disease status, progression, and estimated prognosis if clinically appropriate is based on the GSF joint publication [Gold Standards Framework, 2022] and expert opinion in a palliative care textbook [Cherny, 2015].
    • The GSF Proactive Identification Guidance (PIG) is a practical guide for clinicians enabling earlier recognition of decline for people considered to be in their final year(s) of life. It aims to support earlier identification of people nearing the end of life and to help estimate prognosis, enabling better anticipation of their needs and provision of supportive care, co-ordination of care and planning, in line with their needs and wishes. The PIG aims to clarify the triggers that help to identify people earlier, to enable proactive person-centred care. These people should be included on a supportive/palliative/end of life care register in their GP practice or care home  [Gold Standards Framework, 2022].
    • The GSF guidance recognizes that some people may decline the opportunity to engage in advance care planning discussions as this is a voluntary process, and people's decisions should be respected but documented to help inform others involved in their care [Gold Standards Framework, 2022].
  • The information about discussing a person's prognosis is extrapolated from the NICE guideline [NICE, 2021b] and expert opinion in a palliative care textbook [Cherny, 2015]. It is also pragmatic, based on what CKS considers to be good clinical practice.
    • The NICE guideline notes that 'the ways in which people die and how long this takes varies widely, mostly because of the underlying diseases responsible but also the person's robustness or frailty, and their social setting'. Some people may die suddenly and unexpectedly, whereas some with chronic medical conditions may gradually or intermittently decline over weeks or months.
    • Expert opinion in a palliative care textbook notes that most people with a cancer diagnosis want information about their prognosis, but there are often discrepancies between the person and healthcare professionals' perceptions about how much information is needed and what it means to the person. It states that clinicians tend to underestimate the amount of prognostic information a person needs, and overestimate how much the person has understood about their illness and its likely outcome. It highlights that inconsistent prognostic information can be distressing and unhelpful to the person, and they are grateful for hopeful messages, even in the context of a known terminal phase of illness [Cherny, 2015].
  • The recommendation to discuss and document advance care planning is largely based on the NICE guideline [NICE, 2021b], together with the GMC publication [GMC, 2024] and expert opinion in palliative care textbooks [Regnard, 2010; Cherny, 2015; Twycross, 2021].
    • Expert opinion in a palliative care textbook cites study evidence that discussion of end of life issues may be associated with less aggressive medical care near death, earlier hospice referrals, more appropriate place of care settings, and improved outcomes for bereaved family members. In particular, unnecessary and lengthy hospital admissions can be avoided by effective advance care planning. It enables the person to have a better understanding of what lies ahead and have time to deal with the news and realign their priorities. It also ensures they receive the support they need when making important decisions relating to their future care needs [Cherny, 2015].

How should I recognize the terminal phase of illness?

It can often be difficult to be certain that a person is dying, but it is essential to recognize the signs of dying in order to appropriately care for people at the end of life. The 'terminal phase' is defined as a period of irreversible decline in functional status prior to death.

  • Be aware that the 'terminal phase' may last hours to several days. People are likely to be in the terminal phase of illness when they:
    • Deteriorate day-by-day or more rapidly.
    • Have reduced mobility and become progressively weak, fatigued, without an apparent cause (for example due to underlying hypercalcaemia).
    • Express a realization that they are dying.
    • Have reduced cognition, reduced ability to communicate, or social withdrawal.
    • Have a deterioration in level of consciousness.
    • Are delirious, for example characterized by increased restlessness, confusion, and agitation. See the CKS topic on Delirium for more information.
    • Are bed-bound.
    • Take little food or fluid, and have difficulty taking oral medication.
    • Are peripherally cyanosed, have mottled skin, and are cold to the touch.
    • Have an altered breathing pattern, such as Cheyne-Stokes breathing, noisy rattling breathing, or periods of apnoea.

Basis for recommendation

These recommendations are largely based on the National Institute for Health and Care Excellence (NICE) guideline Care of dying adults in the last days of life [NICE, 2021b] and expert opinion in textbooks on palliative care [Regnard, 2010; Cherny, 2015; Twycross, 2021]. 

  • The NICE guideline notes that recognizing dying can be challenging for healthcare professionals when planning care, as the clinical signs may be complex and subtle. It states that correctly recognizing that a person is in the last days of life may allow opportunities for shared decision-making and prevent unnecessary interventions and treatments which may cause distress. In addition, good communication of a dying person's prognosis may improve their end of life clinical care and the bereavement experience of those important to them. It can help to ensure that the dying person's expressed wishes are considered, and may help to avoid misunderstandings about their wishes for care [NICE, 2021b].
  • The definition of the 'terminal phase' is based on expert opinion in a palliative care textbook [Cherny, 2015].
  • The information about clinical features suggesting a person is the terminal phase of illness is based on the NICE guideline [NICE, 2021b] and expert opinion in palliative care textbooks [Regnard, 2010; Cherny, 2015].

What supportive care should be offered in the terminal phase?

If a person is felt to be in the last days of life and entering the terminal phase of illness:

  • Ask about and assess the person's communication needs and mental capacity:
    • Whether they would like a family member or carer to be present when making decisions about their care.
    • Their current level of understanding that they may be nearing death.
    • Their cognitive status and if they have any specific speech, language, or other communication needs.
    • How much information they would like to have about their prognosis. See the section on Assessing prognosis and advance care planning for more information.
    • Their current mental capacity to communicate and actively participate in end of life care and decision-making, including whether they have understood and can retain the information given about their prognosis.
  • Provide the dying person and family members/carers with:
    • Accurate information about their prognosis (unless they do not wish to be informed), explaining any uncertainty and how this will be managed, but avoiding false optimism.
    • An opportunity to talk about any fears and concerns, and to ask questions about their care in the last days of life. The Marie Curie (website www.mariecurie.org.uk) patient information What happens in the last weeks of life and the Hospice UK (website www.hospiceuk.org) information Death and dying: what to expect may be helpful.
    • Information about how to contact members of their care team.
    • Opportunities for further discussion with a member of their care team.
  • Assess the person's physiological, psychological, social, cultural, religious, or spiritual needs and manage appropriately. See the section on Assessment and management approach for more information.
  • Review the advance care planning wishes of the dying person, including any advance statement or preferences about their care in the last days of life (including any anticipatory prescribing decisions, an advance decision to refuse treatment, or details of any legal lasting power of attorney for health and welfare). Recognize that the dying person's ability and desire to be involved in decision-making about their care may change as their condition deteriorates or as they accept their prognosis.
    • Continue to explore the understanding, goals, and wishes of the dying person and those important to them, and update any individualized care plan as needed.
    • It is normally possible and desirable to meet the wishes of a dying person, but when this is not possible, explain the reason why to the dying person and those important to them.
  • Support the dying person to drink and maintain hydration if they wish to and are able to.
    • Regularly assess the person's hydration status, level of consciousness, any swallowing problems, risk of aspiration, and their level of thirst.
    • Discuss the risks and benefits of continuing to drink, with the person and family members/carers.
    • Ensure that healthcare professionals and carers offer frequent mouthcare, including frequent sips of fluid; provision of drinking aids if needed; and help with cleaning teeth or dentures. See the CKS topic on Palliative care - oral for more information.
    • Consider a time-limited trial of 'clinically assisted hydration' with subcutaneous infusion of fluids (such as 1 L of normal saline over 24 hours) if the person has distressing symptoms or signs associated with dehydration such as excessive thirst or delirium, respecting the person's wishes and preferences, and any advance statement or advance decision to refuse treatment.
      • Be aware that clinically assisted hydration may relieve distressing symptoms or signs related to dehydration, but may cause additional issues such as fluid overload, or discomfort or swelling at the infusion site. It is uncertain whether clinically assisted hydration prolongs life or extends the dying process, or whether not giving clinically assisted hydration accelerates the dying process.
      • Monitor the person at least every 12 hours for signs of clinical benefit or harm such as fluid overload, and reduce or stop clinically assisted hydration if there are signs of harm or if the person no longer wants it.
      • If a person is already dependent on clinically assisted hydration before the last days of life, review the risks and benefits of continuing it with the person and family members/carers. Consider whether to continue, reduce, or stop clinically assisted hydration as the person approaches death.
      • The General Medical Council (GMC) publication Treatment and care towards the end of life: good practice in decision making (2024) provides information for healthcare professionals about decision-making, capacity, advance care planning including advance requests for treatment and advance refusals of treatment, nutrition and hydration, CPR, and care after death.
  • Offer symptom management in the last days of life, to maintain the person's comfort and dignity without causing unacceptable adverse effects, wherever possible:
    • De-prescribe any unnecessary drug treatments which are not providing symptomatic benefit or that may cause harm. The British Geriatric Society clinical guide Pragmatic prescribing to reduce harm for older people with moderate to severe frailty may be helpful.
    • Manage specific common symptoms including any reversible causes. Symptoms may include breathlessness, noisy respiratory secretions, pain, nausea and vomiting, constipation, anxiety, agitation and delirium, and skin issues. See the CKS topics on Delirium, Palliative care - constipation, Palliative care - cough, Palliative care - dyspnoea , Palliative care - malignant skin ulcer, Palliative care - nausea and vomiting, Palliative cancer care - pain , and Palliative care - secretions for more information.
    • Offer non-drug and drug treatments for symptom control, taking into account:
      • The person's place of care and the time it would take to obtain medication and/or equipment.
      • The likelihood of specific symptoms and the likely cause(s) of any symptoms.
      • The dying person's individual preferences.
      • The relative benefits and harms of prescribing medication or not prescribing medication.
      • Any risks of the medication that could affect prescribing decisions, including potential drug interactions and comorbidities.
      • The risk of sudden deterioration (such as catastrophic haemorrhage, airway obstruction, or uncontrolled seizures), for which emergency symptom control may be needed.
      • The most effective route for administering medication tailored to the dying person's condition, including their ability to swallow safely and personal preferences. Consider using the subcutaneous route if the person is unable to take or tolerate oral medication.
  • Arrange anticipatory prescribing of medications such as morphine, midazolam, cyclizine, and hyoscine butylbromide for new or developing symptoms so they can be treated without delay.
    • Ensure that the indications and dosage of medication is clearly documented in the person's individualized care plan. Review the individualized care plan and drug prescribing as the person's needs change over time.
    • Start prescribing the lowest effective dose of medication on an 'as required' basis if the person has not previously been given medication for symptom control, and titrate as clinically indicated. Ensure the person is reviewed at least daily to assess symptom response and for any medication adverse effects, to guide the up-titration of medication.
    • Consider using a syringe driver to administer subcutaneous delivery of medication for continuous symptom control, if more than two or three doses of any 'as required' medication have been given within 24 hours.
  • Liaise with other members of the multidisciplinary general or specialist palliative care team about the person's care needs and prognosis (including where appropriate, out of hours, on-call services, and emergency services), and ensure that this is documented in the person's care record.
  • Seek specialist palliative care advice about supportive care and symptom control if needed, for example if symptoms are not controlled promptly or fully, or there are unwanted medication adverse effects, such as over-sedation.
  • Ensure that family members/carers are aware how and who to contact if symptoms are uncontrolled and when the person dies.

Basis for recommendation

These recommendations are largely based on the National Institute for Health and Care Excellence (NICE) guideline Care of dying adults in the last days of life [NICE, 2021b], the General Medical Council (GMC) publication Treatment and care towards the end of life: good practice in decision making [GMC, 2024], the British Geriatrics Society (BGS) clinical guide Pragmatic prescribing to reduce harm for older people with moderate to severe frailty  [BGS, 2025], and expert opinion in palliative care textbooks [Regnard, 2010; Cherny, 2015; Twycross, 2021].

  • The recommendations about assessing the person's communication needs and mental capacity are largely based on the NICE guideline [NICE, 2021b] and expert opinion in a palliative care textbook [Twycross, 2021].
    • The NICE guideline notes that 'for some people who are entering the last days of life, mental capacity to understand and engage in shared decision-making may be limited. This could be temporary or fluctuating, for example it may be caused by delirium associated with an infection or a biochemical imbalance such as dehydration or organ failure, or it could be a permanent loss of capacity from dementia or other similar irreversible conditions'.
  • The recommendations about information provision are based on the NICE guideline [NICE, 2021b] and expert opinion in palliative care textbooks [Cherny, 2015; Twycross, 2021].
    • Expert opinion in a palliative care textbook notes that failure to recognize and acknowledge the dying phase with the person and family members/carers can have significant implications, including loss of trust in the healthcare team, being more likely to die with unrelieved symptoms, having inappropriate cardiopulmonary resuscitation (CRP), and having a more difficult bereavement. It notes that estimating prognosis for individuals is difficult, as some underlying causes of acute deterioration may be reversible, leading to a temporary improvement in the person's condition. It stresses the importance of regular reviews of treatment and the person's wishes at the end of life [Twycross, 2021]. 
  • The recommendation to review the advance care planning wishes of the person are largely based on the NICE guideline [NICE, 2021b] together with expert opinion in a palliative care textbook [Twycross, 2021].
  • The recommendation to review oral fluids and the need for clinically-assisted hydration is largely based on the NICE guideline [NICE, 2021b] and the GMC publication [GMC, 2024], together with expert opinion in palliative care textbooks [Cherny, 2015; Twycross, 2021].
    • The NICE guideline highlights the importance of ensuring hydration is maintained in the last days of life when needed, to prevent or minimize any unwanted symptoms such as dehydration or delirium. If this is not possible by oral intake, clinically assisted hydration may be beneficial in some circumstances depending on the individualized relative risks and benefits to the person [NICE, 2021b]. The recommendation to consider a time-limited trial of 1 L of normal saline subcutaneously over 24 hours is based on expert opinion in palliative care textbooks, which note that the evidence for clinically-assisted hydration is mixed, with insufficient evidence to draw firm conclusions about its benefits and harms at the end of life [Cherny, 2015; Twycross, 2021].
    • Expert opinion in a palliative care textbook highlights that in the last days of life, maintaining good mouthcare and hygiene can relieve sensations of thirst and discomfort for most people, without the need for clinically assisted hydration [Cherny, 2015].
    • The GMC publication on end of life care notes that the current evidence about the benefits, burdens and risks of providing clinically assisted hydration and nutrition as people approach the end of life is not clear-cut. This can lead to concerns that people who are unconscious or semi-conscious may be experiencing distressing symptoms and complications, or otherwise be suffering either because their needs for nutrition or hydration are not being met, or because attempts to meet their perceived needs for nutrition or hydration may be causing them avoidable suffering. Clinically assisted nutrition and hydration are regarded in law as medical treatment, and should be treated in the same way as other medical interventions. Some people, however, see nutrition and hydration (whether oral or by tube or drip) as part of basic nurture for the person which should almost always be provided. It stresses the importance of listening to and considering the views of the person and of people close to them (including their cultural and religious views), and explaining the issues to be considered, including the benefits, burdens, and risks of providing clinically assisted nutrition and hydration. If clinically assisted nutrition or hydration would be of overall benefit, it will always be offered, and if a decision is taken not to provide clinically assisted nutrition or hydration, the person will continue to receive high-quality care and symptom relief.
  • The recommendations about symptom management are based on the NICE guideline [NICE, 2021b], the BGS clinical guide [BGS, 2025], and expert opinion in a palliative care textbook [Cherny, 2015]. They are also pragmatic, based on what CKS considers to be good clinical practice.
  • The recommendation to arrange anticipatory medication prescribing is based on the NICE guideline [NICE, 2021b] and expert opinion in a palliative care textbook [Twycross, 2021]. 
    • The NICE guideline notes that individualized anticipatory prescribing of medication for symptom control at the end of life should provide more effective symptom relief, reduce the risk of distressing and unnecessary hospital admissions, and reduce wastage of unnecessary or unused medication(s).
  • The recommendation to liaise with other members of the multidisciplinary care team is based on the NICE guideline [NICE, 2021b] and is also extrapolated from the GMC publication [GMC, 2024].
  • The recommendation to seek specialist palliative care advice is extrapolated from the NICE guideline [NICE, 2021b]. It is also pragmatic, based on what CKS considers to be good clinical practice.
  • The recommendation to ensure that family members and carers have essential contact information is based on the NICE guideline [NICE, 2021b] and expert opinion in a palliative care textbook [Cherny, 2015]. 

Supporting evidence

This CKS topic is largely based on the National Institute for Health and Care Excellence (NICE) guidelines Care of dying adults in the last days of life [NICE, 2021b], the General Medical Council (GMC) publication Treatment and care towards the end of life: good practice in decision making [GMC, 2024], together with expert opinion in palliative care textbooks. The rationale for individual recommendations is discussed in the relevant basis for recommendation sections.

How this topic was developed

This section briefly describes the processes used in developing and updating this topic. Further details on the full process can be found in the About Us section and on the Clarity Informatics website.

Search strategy

A literature search was conducted for guidelines, systematic reviews and randomized controlled trials on primary care management of palliative care - general issues.

Search dates

March 2021 - July 2026

Key search terms

Various combinations of searches were carried out. The terms listed below are the core search terms that were used for Medline.

  • exp Palliative Care/, exp Terminal Care/, exp Terminally Ill/, palliat$.tw., (terminal adj care).tw., (palliative or terminal$ or end of life).tw., (advanced adj disease).tw.

Sources of guidelines

Sources of systematic reviews and meta-analyses

  • The Cochrane Library:
    • Systematic reviews
    • Protocols
    • Database of Abstracts of Reviews of Effects
  • Medline (with systematic review filter)
  • EMBASE (with systematic review filter)

Sources of health technology assessments and economic appraisals

Sources of randomized controlled trials

  • The Cochrane Library:
    • Central Register of Controlled Trials
  • Medline (with randomized controlled trial filter)
  • EMBASE (with randomized controlled trial filter)

Sources of evidence based reviews and evidence summaries

Sources of national policy

Patient experiences

Sources of medicines information

The following sources are used by CKS pharmacists and are not necessarily searched by CKS information specialists for all topics. Some of these resources are not freely available and require subscriptions to access content.

Stakeholder engagement

Our policy

The external review process is an essential part of CKS topic development. Consultation with a wide range of stakeholders provides quality assurance of the topic in terms of:

  • Clinical accuracy.
  • Consistency with other providers of clinical knowledge for primary care.
  • Accuracy of implementation of national guidance (in particular NICE guidelines).
  • Usability.

Principles of the consultation process

  • The process is inclusive and any individual may participate.
  • To participate, an individual must declare whether they have any competing interests or not. If they do not declare whether or not they have competing interests, their comments will not be considered.
  • Comments received after the deadline will be considered, but they may not be acted upon before the clinical topic is issued onto the website.
  • Comments are accepted in any format that is convenient to the reviewer, although an electronic format is encouraged.
  • External reviewers are not paid for commenting on the draft topics.
  • Discussion with an individual or an organization about the CKS response to their comments is only undertaken in exceptional circumstances (at the discretion of the Clinical Editor or Editorial Steering Group).
  • All reviewers are thanked and offered a letter acknowledging their contribution for the purposes of appraisal/revalidation.
  • All reviewers are invited to be acknowledged on the website. All reviewers are given the opportunity to feedback about the external review process, enabling improvements to be made where appropriate.

Stakeholders

  • Key stakeholders identified by the CKS team are invited to comment on draft CKS topics. Individuals and organizations can also register an interest to feedback on a specific topic, or topics in a particular clinical area, through the Getting involved section of the Clarity Informatics website.
  • Stakeholders identified from the following groups are invited to review draft topics:
    • Experts in the topic area.
    • Professional organizations and societies (for example, Royal Colleges).
    • Patient organizations, Clarity has established close links with groups such as Age UK and the Alzheimer’s Society specifically for their input into new topic development, review of current topic content and advice on relevant areas of expert knowledge.
    • Guideline development groups where the topic is an implementation of a guideline.
    • The British National Formulary team.
    • The editorial team that develop MeReC Publications.
  • Reviewers are provided with clear instructions about what to review, what comments are particularly helpful, how to submit comments, and declaring interests.

Patient engagement

Clarity Informatics has enlisted the support and involvement of patients and lay persons at all stages in the process of creating the content which include:

  • Topic selection
  • Scoping of topic
  • Selection of clinical scenarios
  • First draft internal review
  • Second draft internal review
  • External review
  • Final draft and pre-publication

Our lay and patient involvement includes membership on the editorial steering group, contacting expert patient groups, organizations and individuals.

Evidence exclusion criteria

Our policy

Scoping a literature search, and reviewing the evidence for CKS is a methodical and systematic process that is carried out by the lead clinical author for each topic. Relevant evidence is gathered in order that the clinical author can make fully informed decisions and recommendations. It is important to note that some evidence may be excluded for a variety of reasons. These reasons may be applied across all CKS topics or may be specific to a given topic.

Studies identified during literature searches are reviewed to identify the most appropriate information to author a CKS topic, ensuring any recommendations are based on the best evidence. We use the principles of the GRADE and PICOT approaches to assess the quality of published research. We use the principles of AGREE II to assess the quality of published guidelines.

Standard exclusions for scoping literature:

  • Animal studies
  • Original research is not written in English

Possible exclusions for reviewed literature:

  • Sample size too small or study underpowered
  • Bias evident or promotional literature
  • Population not relevant
  • Intervention/treatment not relevant
  • Outcomes not relevant
  • Outcomes have no clear evidence of clinical effectiveness
  • Setting not relevant
  • Not relevant to UK
  • Incorrect study type
  • Review article
  • Duplicate reference

Organizational, behavioural and financial barriers

Our policy

The CKS literature searches take into consideration the following concepts, which are discussed at the initial scoping of the topic.

  • Feasibility
    • Studies are selected depending on whether the intervention under investigation is available in the NHS and can be practically and safely undertaken in primary care.
  • Organizational and Financial Impact Analysis
  • Studies are selected and evaluated on whether the intervention under investigations may have an impact on local clinical service provision or national impact on cost for the NHS. The principles of clinical budget impact analysis are adhered to, evaluated and recorded by the author. The following factors are considered when making this assessment and analysis.
    • Eligible population
    • Current interventions
    • Likely uptake of new intervention or recommendation
    • Cost of the current or new intervention mix
    • Impact on other costs
    • Condition-related costs
    • In-direct costs and service impacts
    • Time dependencies
  • Cost-effectiveness or cost-benefit analysis studies are identified where available. 

We also evaluate and include evidence from NICE accredited sources which provide economic evaluations of recommendations, such as NICE guidelines. When a recommended action may not be possible because of resource constraints, this is explicitly indicated to healthcare professionals by the wording of the CKS recommendation.

Declarations of interest

Our policy

Clarity Informatics requests that all those involved in the writing and reviewing of topics, and those involved in the external review process to declare any competing interests. Signed copies are securely held by Clarity Informatics and are available on request with the permission of the individual. A copy of the declaration of interest form which participants are asked to complete annually is also available on request. A brief outline of the declarations of interest policy is described here and full details of the policy is available on the Clarity Informatics website. Declarations of interests of the authors are not routinely published, however competing interests of all those involved in the topic update or development are listed below. Competing interests include:

  • Personal financial interests
  • Personal family interest
  • Personal non-financial interest
  • Non-personal financial gain or benefit

Although particular attention is given to interests that could result in financial gains or losses for the individual, competing interests may also arise from academic competition or for political, personal, religious, and reputational reasons. An individual is not obliged to seek out knowledge of work done for, or on behalf of, the healthcare industry within the departments for which they are responsible if they would not normally expect to be informed.

Who should declare competing interests?

Any individual (or organization) involved in developing, reviewing, or commenting on clinical content, particularly the recommendations should declare competing interests. This includes the authoring team members, expert advisers, external reviewers of draft topics, individuals providing feedback on published topics, and Editorial Steering Group members. Declarations of interest are completed annually for authoring team and editorial steering group members, and are completed at the start of the topic update and development process for external stakeholders.

Competing interests declared for this topic:

None.

References

  • BGS (2025) Pragmatic prescribing to reduce harm for older people with moderate to severe frailty. British Geriatrics Society. https://www.bgs.org.uk [Free Full-text]
  • Cherny, N., Fallon, M., Kaasa, S., Portenoy, R. et al. (Eds.) (2015) Oxford textbook of palliative medicine. Oxford: Oxford University Press.
  • GMC (2024) Treatment and care towards the end of life: good practice in decision making. General Medical Council. https://www.gmc-uk.org [Free Full-text]
  • Gold Standards Framework (2022) Proactive Identification Guidance (PIG). Gold Standards Framework. https://www.goldstandardsframework.org.uk [Free Full-text]
  • NICE (2015) Care of dying adults in the last days of life (NICE guideline). National Institute for Health and Care Excellence. http://www.nice.org.uk [Free Full-text]
  • NICE (2020) Decision making and mental capacity Quality Standard. National Institute of Health and Care Excellence. http://www.nice.org.uk [Free Full-text]
  • NICE (2021a) Quality standard: End of life care for adults. National Institute for Health and Care Excellence. https://www.nice.org.uk [Free Full-text]
  • NICE (2021b) Care of dying adults in the last days of life. National Institute of Health and Care Excellence. https://www.nice.org.uk [Free Full-text]
  • Regnard, C. and Dean, M. (2010) A guide to symptom relief in palliative care. 6th edn. Oxford: Radcliffe Publishing.
  • Twycross, R., Wilcock, A. and Toller, C.S. (Eds.) (2021) Introducing palliative care. London: Pharmaceutical Press.
  • WHO (2002) National cancer control programmes. Policies and managerial guidelines. World Health Organization. http://www.who.int [Free Full-text]
Change privacy settings